about
TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progression.Metabolic and toxicological considerations of newly approved prostate cancer drugs.Disruption of prostate epithelial differentiation pathways and prostate cancer development.Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis.Identification, characterization and targeting of Docetaxel-resistant prostate cancer cells.[Pathophysiology and therapy of castration-resistant prostate cancer].CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer.
P2860
Q34379050-CE136D4D-CE07-4B09-B364-A5E7D0E41E43Q38098596-CDCFCE27-F948-4C1A-AA88-B03AA2E579AEQ38160495-4BB5A024-1A79-47C7-A357-D59AE8F7DC4FQ38862880-28FFAF94-ECE1-46BC-8175-509E5604655FQ42140492-B0C0CA65-1181-4805-B54D-4CCDDF633F0CQ45021228-4D9D9113-5277-4830-A75E-53FDA02F0E1AQ47740995-36CEF9E0-B5C9-4AD1-B5D2-88DC53292B5A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Overcoming castration resistance in prostate cancer.
@en
Overcoming castration resistance in prostate cancer.
@nl
type
label
Overcoming castration resistance in prostate cancer.
@en
Overcoming castration resistance in prostate cancer.
@nl
prefLabel
Overcoming castration resistance in prostate cancer.
@en
Overcoming castration resistance in prostate cancer.
@nl
P1476
Overcoming castration resistance in prostate cancer.
@en
P2093
Che-Kai Tsao
Matthew D Galsky
P304
P356
10.1097/MOU.0B013E3283523B8B
P577
2012-05-01T00:00:00Z